Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The academy has secured partnerships with 15 esteemed hospitals
Cipla had earlier invested € 15 million in Ethris in 2022
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Need to harmonize traditional and modern medicine to combat alarming health problems
Cipla and Ethris partner for the development of mRNA-based therapies
Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
 
        Subscribe To Our Newsletter & Stay Updated